Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SP-RAIL: The Morbidity and Safety of Single-port Robotic-assisted Inguinofemoral Lymphadenectomy in Vulvar Squamous Cell Carcinoma - a Randomized Controlled Phase II Trial

NCT07853287 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07853287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07853287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SP-RAIL: The Morbidity and Safety of Single-port Robotic-assisted Inguinofemoral Lymphadenectomy in Vulvar Squamous Cell Carcinoma - a Randomized Controlled Phase II Trial
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2030
Enrollment
64 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vulvar cancers